These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34887530)

  • 1. Role of the microbiota in hypertension and antihypertensive drug metabolism.
    Mishima E; Abe T
    Hypertens Res; 2022 Feb; 45(2):246-253. PubMed ID: 34887530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome and hypertension: where are we now?
    Vallianou NG; Geladari E; Kounatidis D
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure.
    Tokarek J; Budny E; Saar M; Kućmierz J; Młynarska E; Rysz J; Franczyk B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
    Hsu CN; Tain YL
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension.
    Mu YF; Gao ZX; Mao ZH; Pan SK; Liu DW; Liu ZS; Wu P
    Hypertens Res; 2024 Sep; 47(9):2351-2362. PubMed ID: 38877311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension.
    Vallianou NG; Kounatidis D; Panagopoulos F; Evangelopoulos A; Stamatopoulos V; Papagiorgos A; Geladari E; Dalamaga M
    Curr Hypertens Rep; 2023 Nov; 25(11):367-376. PubMed ID: 37632662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
    Hsu CN; Hou CY; Hsu WH; Tain YL
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System.
    Robles-Vera I; Toral M; Duarte J
    Am J Hypertens; 2020 Oct; 33(10):890-901. PubMed ID: 32614942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiota and blood pressure in experimental models.
    Jama HA; Kaye DM; Marques FZ
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and cardiovascular diseases axis.
    Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
    Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs.
    Xiong Y; Xiong Y; Zhu P; Wang Y; Yang H; Zhou R; Shu Y; Zhou H; Li Q
    Curr Hypertens Rep; 2021 Sep; 23(8):40. PubMed ID: 34487269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food Peptides, Gut Microbiota Modulation, and Antihypertensive Effects.
    Tsafack PB; Li C; Tsopmo A
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Dysbiosis and Kidney Diseases.
    Cao C; Zhu H; Yao Y; Zeng R
    Front Med (Lausanne); 2022; 9():829349. PubMed ID: 35308555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension.
    Suswał K; Tomaszewski M; Romaniuk A; Świechowska-Starek P; Zygmunt W; Styczeń A; Romaniuk-Suswał M
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and hypertension: association, mechanisms and treatment.
    Yang Z; Wang Q; Liu Y; Wang L; Ge Z; Li Z; Feng S; Wu C
    Clin Exp Hypertens; 2023 Dec; 45(1):2195135. PubMed ID: 36994745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Gut Microbiota in Children with Kidney Disease.
    Tain YL; Hsu CN
    Children (Basel); 2023 Jan; 10(2):. PubMed ID: 36832398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.